MétaCan
Menu
Back to cohort
Record W4406224453 · doi:10.1002/alz.090018

Nonpharmacologic Management of Behavioral and Psychological Symptoms of Dementia in Community‐Residing Persons with Moderately‐Severe Alzheimer’s Disease: One Year Results from a Randomized Controlled Trial

2024· article· en· W4406224453 on OpenAlexaff
Sunnie Kenowsky, Yongzhao Shao, Sloane Heller, James Golomb, Alok Vedvyas, Gianna Dafflisio, Qiao Zhang, Harris Torossian, Martin Sadowski, Thomas Wısnıewskı, Arjun V. Masurkar, ‌Barry Reisberg

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsMcGill University Health Centre
Fundersnot available
KeywordsDementiaRandomized controlled trialPhysical therapyMedicineDiseasePsychologyClinical psychologyPhysical medicine and rehabilitationGerontologyPsychiatryInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Behavioral and psychological symptoms of dementia (BPSD) occur frequently in persons with Alzheimer’s disease (PAD). They cause suffering, institutionalization, carepartner distress, depression, burden, and decreased PAD‐carepartner quality of life. Brexpiprazole approval advanced the AD treatment armamentarium. However, pharmacologic treatment options have limited effectiveness and may have serious adverse effects. Therefore, nonpharmacologic interventions are recommended as first‐line treatments. Nevertheless, much still needs to be accomplished to ameliorate PAD‐carepartner outcomes including improving access to implementable, comprehensive, individualized, effective care and trained professionals. We conducted a 28‐week, randomized, controlled, clinician‐blind, parallel group study (Reisberg…Kenowsky, Dement Geriatr Cogn Disord. 2017), in which moderately‐severe PAD‐carepartner dyads (N = 20) received memantine and a comprehensive, individualized, person‐centered management program (CI‐PCM, n = 10) or usual community care (UCC, n = 10), followed by a 24‐week extension study. In the 28‐week study, carepartners learned to identify BPSD and their causes, communicate and engage PAD effectively, manage and treat medical issues and pain, meet PAD needs, employ behavioral and psychological strategies to manage and prevent BPSD, and techniques to restore PAD abilities and skills. We report 52‐week behavioral outcomes. Methods All 28‐week study subjects entered the 24‐week extension during which one UCC subject died. CI‐PCM carepartners implemented training and tools learned in the 28‐week study. Minimal assistance by the AD care specialist consisted of every two‐month home visits and ad hoc telephone consultations. BPSD were assessed using the Behavioral Pathology in Alzheimer’s Disease Frequency Weighted severity scale (BEHAVE‐AD‐FW). The Revised Memory and Behavior Problems Checklist, Reaction Rating (RMBPC‐RR) was used to assess carepartner reaction to BPSD. P values for difference from baseline to 52‐weeks were determined using the Wilcoxon‐Mann‐Whitney test. Cohen’s d was calculated to estimate effect size. Results BEHAVE‐AD‐FW showed significant improvement in CI‐PCM subjects for severity and frequency of total BPSD (Figure 1, p = 0.01, Cohen’s d = 1.203), paranoid and delusional ideation (p = 0.011) and agitation (specifically, aggressivity, p = 0.041). CI‐PCM carepartner distress, depression and burden significantly decreased (RMBPC‐RR, Figure 2, p = 0.004, Cohen’s d = 1.45). Conclusions CI‐PCM is an effective, readily implemented program that significantly decreased total BPSD, aggressivity, and paranoid and delusional ideation in moderately‐severe PAD and significantly improved carepartner distress, depression and burden.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.003
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.081
GPT teacher head0.357
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207